Summary. Urinary excretion of oestrone conjugates, pregnanediol-3\g=a\-glucuronide (PdG) and 20\g=a\-hydroxypregn-4-en-3-one were measured from 8 weeks before oestrus to 2 weeks post partum and bioactive FSH was monitored during the periovulatory interval in a female giant panda. A biphasic urinary bioactive FSH excretory profile appeared to indicate a broad (~1 0 day) follicular phase followed by a sharp preovulatory bioactive FSH surge coincident with an acute increase in urinary oestrone conjugates and behavioural oestrus. Weekly concentrations of urinary oestrone conjugates and PdG increased (P < 0\m=.\001)by Week 9 of gestation with 20\g=a\-hydroxypregn-4-en\x=req-\ 3-one levels increasing 10\p=n-\30-fold (P < 0\m=.\001) between Weeks 11 and 14. These observations indicate that the monoestrous giant panda does not appear to require a prolonged period of endogenous FSH release or multiple FSH peaks for ovarian priming and follicle selection to proceed normally. Furthermore, the delayed rise in urinary steroid excretion during the second half of gestation in the giant panda supports the concept of delayed implantation while the estimation of steroid conjugates in urine offers a non-invasive approach for monitoring pregnancy status in this endangered species.
Introduction
The giant panda (Ailuropoda melanoleucd) once inhabited most of the mountainous bamboo forests in southeast China, but today the wild population (estimated at only 1000 individuals) is confined to 6 mountain preserves in the Gansu, Shaanxi and Sichuan provinces (Knight et al, 1985; Hoessle et al, 1988) . Currently, about 80 giant pandas are maintained in captivity in China while 18 pandas are housed in zoological parks outside that country (Hoessle et al, 1988) . Females are seasonally monoestrous with a single 2-3-day period of sexual receptivity usually occurring from March to May (Anon., 1974) . Although more than 40 giant panda cubs have been born in captivity in China, few have survived to maturity. Because only 6 surviving offspring have been produced in western zoos since 1937, a more detailed understanding of the reproductive biology of this animal is required.
A gradually increasing database is being developed for this species, including the successful use of artificial breeding. Reports are available on the collection, analysis and freezing of giant panda semen (Platz et al, 1983 ) and 3 females have given birth after artificial insemination with fresh or thawed spermatozoa Masui et al, 1988) . Details of reproductive behaviour including courtship and mating patterns have been described (Kleiman et al., 1979; Kleiman, 1985) . Bonney et al. (1982) reported increased urinary oestrogens in the female giant panda during the pro-oestrous interval while oestrogen concentrations declined during the period of sexual receptivity. In 1984, Hodges et al. confirmed ovulation and pregnancy in the giant panda by using non-invasive direct radioimmunoassay (RIA) of urinary steroidal metabolites. This work, which examined one complete pregnancy, suggested that the post-ovulatory rise in a progesterone metabolite PdG) was extremely attenuated, but by Week 12 after oestrus (75% of gestation) PdG levels increased 4-fold above post-ovulatory concentrations, suggesting obligate delayed implantation. These observations were confirmed during pregnancy in Ling-Ling, the giant panda at the National Zoological Park (1984) , while in 1985, a rise in urinary PdG levels 10 weeks after gonadotrophin-induced ovulation (with exogenous FSH-P) and mating with no subsequent birth provided circumstantial evidence that the species may experience pseudopregnancy (Chaudhuri et ai, 1988) .
To date, the endocrine events associated with the periovulatory interval, pseudopregnancy or pregnancy have been described by measuring only a single, or at most 2, hormonal metabolites in samples often collected at sporadic intervals. The secretory patterns of gonadotrophins, including FSH associated with follicular/ovulatory activity, are unknown for the giant panda. Historically, the quantification of physiological FSH concentrations in biological fluids has been limited by the lack of sensitive and specific assay techniques. However, an in-vitro granulosa cell aromatase bio¬ assay has now been described for measuring FSH in biological fluids (Jia & Hsueh, 1985 , 1986 Dahl et al, 1987b) . In addition to measuring bioactive rather than immunoreactive FSH, this approach is non-species specific and already has been broadly applied to the human, gorilla (Gorilla gorilla), lion-tailed macaque (Macaca silenus), golden monkey (Rhinopithecus roxellana), giraffe (Giraffa camelopardalis), Asian elephant (Elaphas maximus) and killer whale (Orcinus orcus) (Dahl et al, 1987a, b; Walker et al, 1987) .
In 1987, the giant panda Ling-Ling, at the age of 18 years, experienced a behaviourally normal oestrus, copulation, pregnancy and parturition. The opportunity to collect frequent urine samples provided a unique opportunity to detail and integrate retrospectively 3 urinary steroid metabolites and urinary bioactive FSH with known reproductive events.
Materials and Methods
Animals and sample collection. Housing and management of the giant pandas at the National Zoological Park have been described (Collins & Page, 1973) . Generally, Ling-Ling and the male giant panda Hsing-Hsing are maintained separately in indoor-outdoor enclosures within visual, aural and olfactory proximity. However, animals are permit¬ ted direct access to each other from 07:00 to 11:00 h on 3 days/week except during the breeding season when they are placed together on a daily basis. Behavioural signs indicative of onset of oestrus, including a marked increase in anogenital rubbing, vocalizations and scent marking, have been described in detail (Kleiman el al., 1979) . Early morning urine samples were aspirated from the indoor, concrete enclosure floor and stored individually without preservatives until assayed. Urine was analysed for creatinine (Cr) content (Taussky, 1954) (19-5-5000 pg/tube: Sigma Chemical Co.) were incubated in duplicate overnight (4°C) . After the addition of 300 µ charcoal-dextran (0-0625% charcoal, 0-00625% dextran), antibody bound and free steroid were separated with a 45-min incubation at 4°C. After centrifugation (1500 g for 10 min), supernatants were decanted into scintillation vials and counted in 50 ml Ready Solv-HPb for 5 min.
Serial dilutions of panda urine yielded displacement curves parallel to that obtained with standard preparations. Recovery of known amounts of PdG (range, 39 to 2500 pg/tube) added to a pool of diluted panda urine (50 µ , 1:5) gave a mean ( + s.e.m.) value of 99-5+ 1-6% (y = 1-Ojc -12-6, r= 1-0, < 0-0001). Assay sensitivity was 19-5 pg/tube and inter-assay coefficients of variation were 6-2% and 7-3% respectively, for 2 separate internal controls, and intra-assay variation was <5% (n = 10).
Assay of 20a-hydroxypregn-4-en-3-one. Urinary 20a-hydroxypregn-4-en-3-one was analysed using the method of Shideler et al. (1985) with minor modifications. A portion of urine (10 µ ) was pretreated with 900 µ absolute ethanol similar to the pretreatment of PdG. Supernatants were evaporated and reconstituted in 300 µ phosphate buffer (0-1 M, 0-1 % gelatin, pH 70). Antibody directed against PdG-bovine serum albumin ( 100 µ , 1:2000: provided by S. Tillson, Syva Corp., Palo Alto, CA, USA) was added to the sample with [3H]20a-hydroxypregn-4-en-3-one, µ /tube, 7500 c.p.m., sp. act. 60 Ci/mmol: Dupont-New England Nuclear). The antiserum has the following cross-reactivities: 20a-hydroxypregn-4-en-3-one, 100%; PdG, 53%; allopregnanediol, 28%; 5a-pregnane-3ß,20a-diol, 19%; pregnane¬ diol, 16%; 20ß-hydroxypregn-4-en-3-one, 1%. Standards ranged from 31 to 5000 pg/tube and incubation tubes were refrigerated (4°C) for 24 h before 500 µ charcoal-dextran separation of bound and free hormone.
The mean ( + s.e.m.) percentage recovery of unlabelled 20a-hydroxypregn-4-en-3-one was 1060 + 5-3% (range, 10-625 pg) and the regression equation was y = 1 4 -2-15, r = . Serial dilutions of a late pregnancy urine pool yielded a parallel dose-response curve. Inter-and intra-assay coefficients of variation were 18% and 14%, respectively while assay sensitivity was 78 pg/tube.
Granulosa cell aromatase bioassay. Bioactive FSH concentrations were measured using an in-vitro granulosa cell aromatase bioassay with modifications as previously described (Jia & Hsueh, 1985 , 1986 Dahl et al., 1987b) . Granulosa cells obtained from immature Sprague-Dawley rats treated with diethylstilboestrol were cultured in 16-mm, 24-well culture plates. Each well contained 6 104 viable cells in 0-5 ml McCoy's 5a medium (without serum, Gibco Laboratories, Santa Clara, CA, USA) supplemented with 2 mM-L-glutamine, 100 U penicillin/ml, 100 µg streptomycin sulphate/ml, 10~6 M-androstenedione (Sigma), 10~7 M-diethylstilboestrol (Sigma), 0-125 mM-1-methyl-3-isobutyl xanthine (Sigma), 1 µg insulin/ml (porcine, Dr R. E. Chance, Lilly Research Laboratories, Indianapolis, IN, USA) and 30 ng hCG/ml (Center for Population Research, NICHHD, NIH, Bethesda, MD, USA). Each urine sample was assayed in triplicate at 3 dosage levels (0-1,0-2 and 0-4 µ ). A constant volume of urine (0-4 µ /culture) was maintained in all cultures (total volume, 500 µ ) by the addition of gonadotrophin-free urine from oral contraceptive pill users. For standard curves, gonadotrophin-free urine (0-4 µ ) was added to cultures containing increasing doses of a urinary gonadotrophin (Pergonal) preparation (Menotropins U.S.P., 7-5 i.u. FSH activity/mg, 7-5 i.u. LH activity/ mg; Second International Reference Preparation of human menopausal gonadotrophin: Serono Laboratories, Inc., Randolph, MA, USA) to correct for the effect of urine on the dose-response curve. At the end of the 3-day culture, medium was analysed for oestrogen content by RIA using an oestrogen antiserum (Dr . X. Liu, Institute of Zoology, Academia Sinica, China) as described previously (Jia & Hsueh, 1985) . The sensitivity of the granulosa cell aromatase bioassay was 0 6 mlU/culture for Pergonal with inter-and intra-assay variations of 16% and 12%, respectively.
High-pressure liquid chromatography. To determine the relative contributions of immunoreactive PdG and 20a-hydroxypregn-4-en-3-one excreted during late pregnancy, separate 50 µ portions of urine (at 13% and 83% gestation) were analysed using reverse-phase h.p.l.c. separation. A 5-0 250mm C-l8 reverse phase column (Chemical Engineering Co., Los Angeles, CA, USA) and a gradient flow of acetonitrile (Mallinckrodt, Paris, KY, USA) and water as solvent system were used as follows: 0-10 min, 40% acetonitrile; 10-20 min, 40-100% acetonitrile; 20-30 min, 100% acetonitrile. Flow rate was 1 ml/min and fractions were collected at 0-2 min intervals. 3H-labelled PdG and 20o>hydroxypregn-4-en-3-one (2000 c.p.m.) were used as co-chromatographic markers to identify the elution profiles of the immunoreactive counterparts. Separate portions of column eluates were collected directly for counting of tracer and assayed for immunoreactivity using the 20a-hydroxypregn-4-en-3-one RIA described previously.
Statistical analysis. Statistics were performed using SYSTAT (version 30, Wilkinson, 1987) (Fig. la) was excreted in a biphasic fashion. Baseline concen¬ trations of bioactive FSH (1-2 IU/mg Cr) gradually increased 4-to 5-fold (6-7 IU/mg Cr), forming a broad peak between -4 and -2 weeks, followed by a return to baseline before a sharp 4-day long surge and peak levels of 44-3 IU/mg Cr (30-fold above baseline; Day 0). Mean urinary oes¬ trone conjugates concentration remained low (31 ± 10 ng/mg Cr) during the 8-week interval pre¬ ceding Day 0 (Fig. lb) . By Day -10, oestrone conjugates began a consistent and gradual rise with the preovulatory peak concentration (69-7 ng/mg Cr; Day 0) representing a 20-fold increase over basal levels. The oestrone conjugates peak was followed by a precipitous decline to 4-6 ng/mg Cr by Day 3 with daily concentrations thereafter ranging from 0-3 to 6-4 ng/mg Cr throughout preg¬ nancy. By 8 weeks after the peak of bioactive FSH, weekly mean oestrone conjugates concentration decreased (P < 005) from 3-3 ± 0-7ng/mg Cr (Week 1) to 10 + 0-3ng/mg Cr (Week 8). Mean weekly levels between Weeks 9 and 16 increased steadily and were greater (P < 0001) than mean weekly levels between Weeks 1 and 8, reaching peak pregnancy concentrations of 4-6 + 0-4 ng/mg Cr at 1 week before parturition (Fig. 2a) Mean 20a-hydroxypregn-4-en-3-one concentration during the 8 weeks before Day 0 averaged 311 ±3-3 ng/mg Cr (n = 28) with levels increasing (P < 002) to 45-8 ± 4-9 ng/mg Cr (n = 20) during the 4 weeks immediately after ovulation. The excretory pattern of 20a-hydroxypregn-4-en-3-one remained unchanged through Week 10, but from Weeks 11 to 14 20a-hydroxypregn-4-en-3-one levels increased 10-30-fold to a weekly peak of 5440 + 293-3 ng/mg Cr (peak daily concentration, 1654 ng/mg Cr). The 20ot-hydroxypregn-4-en-3-one excretion rate declined markedly from 13 to 16 weeks and was at pre-oestrus concentrations by 1 week post partum. Although 20a-hydroxypregn-4-en-3-one immunoreactivity during late pregnancy was quanti¬ tatively greater than PdG, reflecting cross-reactivity with PdG and at least 4 other progestagen metabolites (see Fig. 3 ), the relative PdG immunoreactive profile appeared to provide an earlier indication of potential pregnancy as indicated by an earlier increase in metabolite excretion (Fig. 2b) . 
Co-chromatographic separation ofprogestagen metabolites
The h.p.l.c. co-chromatographic profiles of 20a-hydroxypregn-4-en-3-one cross-reactivity obtained from early and late pregnancy urines (13% and 83% of gestation, respectively) are pre¬ sented in Fig. 3(a, b) bioactive FSH remains to be elucidated, these data, and results of previous studies (Jia & Hsueh, 1985 , 1986 Dahl et al, 1987a, b; Walker et al, 1987) suggest that early morning urinary bioactive FSH levels reflect serum bioactive FSH concentrations and may serve as a valuable index for estimating FSH secretory activity. The extreme sensitivity and lack of species specificity make this approach particularly appropriate for species, such as the giant panda, for which adequate RIAs are unavailable. The female in this report exhibited a biphasic urinary profile of bioactive FSH consisting of a single follicular-phase peak followed by a preovulatory surge. These temporal patterns were qualitatively similar to those reported for the human, lion-tailed macaque, giraffe and killer whale (Dahl et al, 1987a, b; Walker et al., 1987 The periovulatory excretory profiles for oestrone conjugates reported here were similar to pre¬ vious reports for the giant panda (Bonney et al, 1982; Hodges et al, 1984; Chaudhuri et al, 1988; Masui et al, 1988 (Dahl et al, 1987b) . The seemingly late peak of oestrone conjugates probably reflects overproduction of hormone beyond the threshold stimulatory levels required for the events leading to ovulation.
In general, we observed a qualitatively similar PdG excretion profile to that reported earlier for this species Chaudhuri et al, 1988; Masui et al, 1988) . Hodges et al. (1984) observed no substantial increase in PdG until 120 days after ovulation while Chaudhuri et al. (1988) reported increased PdG excretion immediately following ovulation. Our results indicate that mean weekly PdG and 20a-hydroxypregn-4-en-3-one excretion increased significantly during the 30-day interval after oestrus, demonstrating that the giant panda does exhibit a discernible lutealphase increase in progestagen metabolite excretion. Hodges et al (1984) additionally suggested that giant pandas may undergo an obligate delay of implantation, similar to that observed in the European badger (Bonnin et al, 1978) , western spotted skunk (Mead & Eik-Nes, 1969a, b; , mink (Cochrane & Shackelford, 1962; Moller, 1973) , roe deer (Short & Hay, 1966; Aitken, 1974) and black bear (Foresman & Daniel, 1983) . In these animals, soon after conception, embryonic development is arrested at the blastocyst stage followed by a variable period of embryonic diapause (Wimsatt, 1963) . The arrested embryo is induced to attach physically to the uterine endometrium by an unknown signal which triggers a resumption of metabolic activity (Gulyas & Daniel, 1967) . Although evidence that the giant panda exhibits delayed implantation is circumstantial, the variable gestation length for the species days) combined with the immaturity and low birthweight of newborn cubs are consistent with an abbreviated period of fetal development . Additionally, abrupt acceleration in PdG and 20a-hydroxypregn-4-en-3-one excretion long after ovulation suggests that maternal ovaries or newly formed placental tissues are responding to an unknown stimulus from the implanting embryo. Similarly, the late gestational rise in the oestrogen metabolite may reflect placental production and/or fetal-maternal biosynthesis. Although the preimplantation interval appears quite variable in duration, post-implantational fetal development seems to be relatively fixed, terminating in parturition 4-6 weeks after an increase in the excretion of progestagen metabolites.
The assay for 20a-hydroxypregn-4-en-3-one clearly detects a variety of progesterone metab¬ olites and represents a cumulative measurement of several progestagens. Although these data reflect only a single animal and should be interpreted with caution, this broad-spectrum antiserum is useful for identifying other potentially important progestagens excreted during pregnancy in the giant panda. Comparison of h.p.l.c. co-chromatographs from early and late gestation suggests that, in addition to PdG and 20a-hydroxypregn-4-en-3-one, at least 4 other progestagens are excreted during late pregnancy. Even though further work is required to elucidate the precise nature of these metabolites, their presence may indicate a post-implantational increase in fetal and/or fetalplacental-maternal steroid biosynthesis or may reflect an increase in the metabolic by-products of PdG or 20a-hydroxypregn-4-en-3-one. In either case, the 10-fold greater immunoreactivity of 20a-hydroxypregn-4-en-3-one observed during late pregnancy can be attributed to the increased excretion of these 'other' progestagens which cross-react with the 20ot-hydroxypregn-4-en-3-one assay.
From a practical perspective, the short interval required to conduct the laboratory analyses of oestrone conjugates and PdG allowed us to test the usefulness of these techniques for daily repro¬ ductive management. For example, the close relationship between the oestrone conjugates surge and copulatory behaviour permitted identification of the optimal interval for animal pairing. Since the antagonism between the National Zoo's male and female giant panda increases when the female is no longer sexually receptive, daily measures of activity of oestrone conjugates assist in confirm¬ ing the termination of oestrus, thus lessening the chance of animal injury. The marked decline in PdG to baseline levels coincident with parturition also indicated that this procedure was useful for predicting birth, thereby facilitating the mobilization of personnel needed. The efficient estimation of impending parturition, however, necessitates that PdG values be monitored on a daily basis.
The question of pseudopregnancy in giant pandas remains unresolved. To our knowledge, 8 longitudinal urinary steroid profiles have been described in 4 giant pandas housed at different institutions (4 in Washington, 1 in London, 1 in Madrid, and 2 in Tokyo). In each case, PdG concentrations eventually increased after ovulation regardless of pregnancy status. Of the 8 pro¬ files, 6 reflected known pregnancies. Of the remaining 2 profiles, 1 was from an animal experiencing endometrial hyperplasia (London) while the other occurred in Ling-Ling (Washington) even though no birth occurred (Chaudhuri et al, 1988) . It is tempting to suggest that the giant panda may experience spontaneous pseudopregnancy which appears to serve as an autonomous mechan¬ ism for pregnancy protection in certain species in which the conceptus is perhaps a weak regulator of its own security during delayed implantation (Schams et al, 1980) . Whether the unknown progestagens reported in this study can help distinguish between pregnancy and pseudopregnancy remains to be demonstrated. Until this question is answered, the differential diagnosis of pregnancy in this species remains equivocal.
